Conversion of Peripheral CD4+ CD25- Naive T Cells to CD4+ CD25+ Regulatory T Cells by Ovarian Carcinoma Cell Supernatants

LI Xiao,CHEN Huai-zeng,YE Feng,L(U) Wei-guo,HONG Die,CHEN Xiao-jun,XIE Xing

DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.02.006

2006-01-01

Abstract:Objective To investigate whether the supernatant from cultured ovarian carcinoma cell line SKOV3 could convert peripheral CD4~+CD25~- T cells into CD4~+CD25~+ regulatory T cells. Methods CD4~+CD25~- T cells isolated from the peripheral blood of healthy woman were activated with plate-bound anti-CD3 and anti-CD28, which were used as the control group. The supernatant of cultured ovarian carcinoma cell line was added to the activated cells as the experiment group. After 72 h, the cells of both groups were harvested separately and further sub-populated into CD25~- and CD25~+ T cells. The cell proliferation was determined by BrdU labelling. Expressions of glucocorticoid-induced TNFR (GITR) and CTLA-4 were tested by flow cytometry. Foxp3 mRNA expression was examined by RT-PCR. Results In contrast to the activated CD4~+CD25~+ T cells, the supernatant-induced CD25~+ T cells which exhibited reduced proliferation capacity and possessed immunosuppressive activity. The supernatant-induced CD25~+ T cells expressed Foxp3 mRNA, GITR and CTLA-4. Conclusion The supernatant derived from SKOV3 converts CD4~+CD25~- T cells into CD4~+CD25~+ regulatory T cells, which is probably responsible for the increasing number of CD4~+CD25~+ regulatory T cells in patients with ovarian carcinoma.